tiprankstipranks
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX

Celldex Stock Price & Analysis

822 Followers

CLDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$19.85 - $57.20
Previous Close$27.98
Volume31.15K
Average Volume (3M)703.84K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$164.04M
Total Debt (Recent Filing)$2.10M
P/E Ratio-13.0
Beta1.08
Next EarningsNov 08, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-2.14
Shares Outstanding46,772,351
R-Squared0.04
Standard Deviation0.58
10 Day Avg. Volume397,399
30 Day Avg. Volume703,838
P/B Ratio3.87
P/S Ratio1588.22
P/CF RatioN/A
P/FCF Ratio-16.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside129.26% Upside
Rating ConsensusStrong Buy
Alpha0.05
Number of Analyst Covering4


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

CLDX FAQ

What was Celldex’s price range in the past 12 months?
Celldex lowest stock price was $19.85 and its highest was $57.20 in the past 12 months.
    What is Celldex’s market cap?
    Currently, no data Available
    When is Celldex’s upcoming earnings report date?
    Celldex’s upcoming earnings report date is Nov 08, 2022 which is in 43 days.
      How were Celldex’s earnings last quarter?
      Celldex released its earnings results on Aug 10, 2022. The company reported -$0.77 earnings per share for the quarter, missing the consensus estimate of -$0.46 by -$0.31.
        Is Celldex overvalued?
        According to Wall Street analysts Celldex’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Celldex pay dividends?
          Celldex does not currently pay dividends.
          What is Celldex’s EPS estimate?
          Celldex’s EPS estimate is -$0.56.
            How many shares outstanding does Celldex have?
            Celldex has 46,772,350 shares outstanding.
              What happened to Celldex’s price movement after its last earnings report?
              Celldex reported an EPS of -$0.77 in its last earnings report, missing expectations of -$0.46. Following the earnings report the stock price went up 5.782%.
                Which hedge fund is a major shareholder of Celldex?
                Among the largest hedge funds holding Celldex’s share is RA Capital Management. It holds Celldex’s shares valued at 56M.

                  ---

                  Celldex Stock Analysis

                  Smart ScoreUnderperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  1
                  The Celldex stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Celldex Therapeutics Inc

                  Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  AbbVie
                  Amgen
                  Gilead Sciences
                  Moderna
                  Vertex Pharmaceuticals

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis